# Evonik plans $27M expansion of German API production sites

Evonik has announced a €25 million ($27 million) first stage of a long-term program to expand capacity at its Dossenheim and Hanau facilities in Germany for contract manufacturing of active pharmaceutical ingredients and advanced intermediates. The first stage is scheduled for completion by mid-2021, with the entire project expected by 2024.

- Type: Expansion
- Announced: 2020-05-05
- Where: Dossenheim and Hanau, Germany, Germany
- Value: $27.0M (25.0M EUR)
- Starts operating: Jul 2021
- Status: announced
- Products: active pharmaceutical ingredients, advanced intermediates
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Evonik Industries](https://endata.com/companies/5809.md)

## Sources

- [manufacturingchemist.com](https://manufacturingchemist.com/evonik-plans-27m-expansion-of-german-api-production-164729), 2020-05-05: "The COVID-19 pandemic has amplified the focus of many pharmaceutical companies to have European-based manufacturing sites that can support the production of their life-saving drug products for reliable supply to regional healthcare markets."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.